Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029002
Filing Date
2025-02-27
Accepted
2025-02-27 16:01:32
Documents
112
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rckt-20241231.htm   iXBRL 10-K 3339176
2 EX-10.24 rckt-ex10_24.htm EX-10.24 49710
3 EX-19 rckt-ex19.htm EX-19 86669
4 EX-21.1 rckt-ex21_1.htm EX-21.1 16007
5 EX-23.1 rckt-ex23_1.htm EX-23.1 5565
6 EX-31.1 rckt-ex31_1.htm EX-31.1 14843
7 EX-31.2 rckt-ex31_2.htm EX-31.2 15611
8 EX-32.1 rckt-ex32_1.htm EX-32.1 14274
9 GRAPHIC img173888082_0.jpg GRAPHIC 962751
10 GRAPHIC img173888082_1.jpg GRAPHIC 570021
11 GRAPHIC img173888082_2.jpg GRAPHIC 531326
12 GRAPHIC img173888082_3.jpg GRAPHIC 342749
13 GRAPHIC img173888082_4.jpg GRAPHIC 396706
  Complete submission text file 0000950170-25-029002.txt   20708165

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rckt-20241231.xsd EX-101.SCH 1954040
115 EXTRACTED XBRL INSTANCE DOCUMENT rckt-20241231_htm.xml XML 2378588
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36829 | Film No.: 25678519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)